Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
- 1 October 2000
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 157 (4), 1239-1246
- https://doi.org/10.1016/s0002-9440(10)64639-1
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (CA 10056)
- U.S. Public Health Service (CA 10056)
This publication has 49 references indexed in Scilit:
- The Resolution of Amyloid SubstanceActa Medica Scandinavica, 2009
- Thermodynamic Instability of Human λ6 Light Chains: Correlation with FibrillogenicityBiochemistry, 1999
- Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell supportBone Marrow Transplantation, 1999
- Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chainsProtein Science, 1999
- Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patientsBritish Journal of Haematology, 1998
- Novel Immunization Protocol and ELISA Screening Methods Used to Obtain and Characterize Monoclonal Antibodies Specific for Human Light Chain Variable-Region SubgroupsHybridoma, 1993
- Macromolecular Properties of Glycosaminoglycans in Primary AL Amyloid Fibril Extracts of Lymphoid Tissue OriginScandinavian Journal of Immunology, 1991
- Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteinsChemical Reviews, 1987
- Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the LiteratureMayo Clinic Proceedings, 1986
- The characterization of soluble amyloid prepared in waterJCI Insight, 1968